AiCure

UBC

Bracket joins ePRO Consortium, program of Critical Path Institute

Friday, March 2, 2012 07:07 AM

Bracket, a division of UBC, has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, which seeks to improve the quality of patient reported outcomes, a crucial element in the drug development process.

More... »


Pfizer signs precision medicine research agreement with Medco

Thursday, October 27, 2011 01:41 PM

Pfizer has established a research collaboration with Medco Health Solutions and its wholly owned subsidiary, United BioSource Corporation (UBC), aimed at more effectively matching patients with treatments that will benefit them the most, thereby improving patient outcomes.

More... »


Sanofi teams up with Medco Health Solutions, UBC

Friday, June 24, 2011 10:29 AM

Sanofi is looking for more ‘real-world’ insight into its drug development and product lifecycle strategies by teaming up with pharmacy benefit manager Medco Health Solutions to help deliver value propositions that can withstand tough scrutiny from regulators and payers, reports PharmaTimes.

More... »

Cimzia shows positive results in RA patients

Tuesday, May 10, 2011 12:02 PM

UCB published results from a post hoc analysis of the RAPID 2 study in the Annals of Rheumatic Diseases, which showed Cimzia, the only approved PEGylated anti-TNF, plus methotrexate (MTX) provided rapid relief from a broad range of symptoms associated with the burden of moderate to severe active rheumatoid arthritis (RA). Adult patients treated with Cimzia that achieved early responses were found to have an increased chance of achieving longer-term outcomes.

More... »

Medco Health Solutions to acquire United BioSource in $730 million all-cash deal

Monday, August 23, 2010 07:00 AM

United BioSource (UBC), a pharmaceutical services company that specializes in post-approval drug research, has agreed to be bought by Medco Health Solutions for $730 million in an all-cash deal as part of the pharmacy-benefit management (PBM) company’s strategy to expand beyond its core business and promote medical treatment based on research evidence.

More... »

Pharmacy benefits manager Medco Health Solutions buys UBC in $730 million all-cash deal

Monday, August 16, 2010 12:52 PM

Medco Health Solutions, the largest pharmacy benefits manager by revenue in the U.S., has agreed to buy closely held United BioSource Corp. (UBC) for $730 million in an all-cash deal.

More... »

UBC to Continue Growth Strategy with New $150 Million in Funding

Monday, July 19, 2010 09:00 AM

Pharmaceutical services company United BioSource Corporation (UBC) will use its newly-secured $150 million line of credit to fuel its fast-paced growth and acquisition spree, CEO Ethan Leder said in an interview with CWWeekly.

More... »

UBC Secures additional $150 million

Wednesday, July 7, 2010 03:00 PM

United BioSource Corporation (UBC), a global scientific and medical affairs organization based in Bethesda, Md., has secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.

More... »

UBC Opens Office In Germany

Thursday, July 1, 2010 07:59 AM

United BioSource Corporation (UBC) launched a new office in Lörrach, Germany, further expanding the company’s clinical research and medical affairs capabilities in Europe.

More... »

UBC Acquires Abt’s Bio-Pharma Business

Monday, May 3, 2010 04:49 PM

United BioSource Corporation (UBC) acquired Abt Bio-Pharma Solutions (ABS), the pharmaceutical and medical device research and consulting arm of Massachusetts-based Abt Associates, for an undisclosed sum.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs